AUTOLUS THERAPEUTICS PLC — Operating Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/f0a3b62c-cfcd-45ed-822f-bfbca640da30/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-270.5M | 2025-01-01 – 2025-12-31 | evidence 0001730463-26-000038 |
| FY 2024 | $-241.4M | 2024-01-01 – 2024-12-31 | evidence 0001730463-25-000019 |
| FY 2023 | $-179.7M | 2023-01-01 – 2023-12-31 | evidence 0001730463-24-000048 |
| FY 2022 | $-143.4M | 2022-01-01 – 2022-12-31 | evidence 0001730463-24-000048 |
| FY 2021 | $-141.1M | 2021-01-01 – 2021-12-31 | evidence 0001730463-24-000048 |
| FY 2020 | $-168.1M | 2020-01-01 – 2020-12-31 | evidence 0001730463-21-000004 |
| FY 2019 | $-146.1M | 2019-01-01 – 2019-12-31 | evidence 0001628280-20-002797 |
| FY 2018 | $-57.5M | 2017-10-01 – 2018-09-30 | evidence 0001628280-20-002797 |
| FY 2017 | $-23.4M | 2016-10-01 – 2017-09-30 | evidence 0001628280-20-002797 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).